Inari Medical Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $66
- Today's High:
- $68.95
- Open Price:
- $67.06
- 52W Low:
- $52.59
- 52W High:
- $83.84
- Prev. Close:
- $67.59
- Volume:
- 608004
Company Statistics
- Market Cap.:
- $3.80 billion
- Book Value:
- 7.607
- Revenue TTM:
- $439.15 million
- Operating Margin TTM:
- -5.13%
- Gross Profit TTM:
- $338.97 million
- Profit Margin:
- -3.66%
- Return on Assets TTM:
- -2.79%
- Return on Equity TTM:
- -3.79%
Company Profile
Inari Medical Inc had its IPO on 2020-05-22 under the ticker symbol NARI.
The company operates in the Healthcare sector and Medical Devices industry. Inari Medical Inc has a staff strength of 1,100 employees.
Stock update
Shares of Inari Medical Inc opened at $67.06 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $66 - $68.95, and closed at $68.13.
This is a +0.8% increase from the previous day's closing price.
A total volume of 608,004 shares were traded at the close of the day’s session.
In the last one week, shares of Inari Medical Inc have increased by +2.71%.
Inari Medical Inc's Key Ratios
Inari Medical Inc has a market cap of $3.80 billion, indicating a price to book ratio of 8.943 and a price to sales ratio of 9.8391.
In the last 12-months Inari Medical Inc’s revenue was $439.15 million with a gross profit of $338.97 million and an EBITDA of $-17370000. The EBITDA ratio measures Inari Medical Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Inari Medical Inc’s operating margin was -5.13% while its return on assets stood at -2.79% with a return of equity of -3.79%.
In Q2, Inari Medical Inc’s quarterly earnings growth was a negative -83.9% while revenue growth was a positive 28.3%.
Inari Medical Inc’s PE and PEG Ratio
- Forward PE
- 1428.5714
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.29 per share while it has a forward price to earnings multiple of 1428.5714 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Inari Medical Inc’s profitability.
Inari Medical Inc stock is trading at a EV to sales ratio of 9.5397 and a EV to EBITDA ratio of -273.7207. Its price to sales ratio in the trailing 12-months stood at 9.8391.
Inari Medical Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $524.97 million
- Total Liabilities
- $58.24 million
- Operating Cash Flow
- $-6080000.00
- Capital Expenditure
- $1.23 million
- Dividend Payout Ratio
- 0%
Inari Medical Inc ended 2024 with $524.97 million in total assets and $0 in total liabilities. Its intangible assets were valued at $524.97 million while shareholder equity stood at $435.65 million.
Inari Medical Inc ended 2024 with $0 in deferred long-term liabilities, $58.24 million in other current liabilities, 57000.00 in common stock, $-46983000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $57.84 million and cash and short-term investments were $337.53 million. The company’s total short-term debt was $1,583,000 while long-term debt stood at $0.
Inari Medical Inc’s total current assets stands at $444.62 million while long-term investments were $0 and short-term investments were $279.70 million. Its net receivables were $63.13 million compared to accounts payable of $7.24 million and inventory worth $38.98 million.
In 2024, Inari Medical Inc's operating cash flow was $-6080000.00 while its capital expenditure stood at $1.23 million.
Comparatively, Inari Medical Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $68.13
- 52-Week High
- $83.84
- 52-Week Low
- $52.59
- Analyst Target Price
- $85.7
Inari Medical Inc stock is currently trading at $68.13 per share. It touched a 52-week high of $83.84 and a 52-week low of $83.84. Analysts tracking the stock have a 12-month average target price of $85.7.
Its 50-day moving average was $62.1 and 200-day moving average was $62.67 The short ratio stood at 4.73 indicating a short percent outstanding of 0%.
Around 1094.6% of the company’s stock are held by insiders while 9412.8% are held by institutions.
Frequently Asked Questions About Inari Medical Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.